−0.01 CAD
−546.60 K CAD
867.94 K CAD
20.97 M
About EASTWOOD BIO-MED CDA INC
Sector
CEO
Youngsoo Kim
Headquarters
Richmond
Website
Founded
2010
FIGI
BBG0069FG7T9
Eastwood Bio-Medical Canada, Inc. is a natural health supplement distribution company. It is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients that are presented in tea or capsule forms. Its products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity. The company was founded on December 10, 2010 and is headquartered in Richmond, Canada.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EBM is 0.98 CAD — it has increased by 78.18% in the past 24 hours. Watch EASTWOOD BIO-MED CDA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange EASTWOOD BIO-MED CDA INC stocks are traded under the ticker EBM.
EBM stock has risen by 30.67% compared to the previous week, the month change is a 2.08% rise, over the last year EASTWOOD BIO-MED CDA INC has showed a −1.01% decrease.
EBM stock is 45.26% volatile and has beta coefficient of −1.65. Track EASTWOOD BIO-MED CDA INC stock price on the chart and check out the list of the most volatile stocks — is EASTWOOD BIO-MED CDA INC there?
Today EASTWOOD BIO-MED CDA INC has the market capitalization of 67.51 M, it has decreased by −26.67% over the last week.
Yes, you can track EASTWOOD BIO-MED CDA INC financials in yearly and quarterly reports right on TradingView.
EBM net income for the last quarter is −115.58 K CAD, while the quarter before that showed −130.14 K CAD of net income which accounts for 11.19% change. Track more EASTWOOD BIO-MED CDA INC financial stats to get the full picture.
No, EBM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EASTWOOD BIO-MED CDA INC EBITDA is −344.34 K CAD, and current EBITDA margin is −45.88%. See more stats in EASTWOOD BIO-MED CDA INC financial statements.
Like other stocks, EBM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EASTWOOD BIO-MED CDA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EASTWOOD BIO-MED CDA INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EASTWOOD BIO-MED CDA INC stock shows the buy signal. See more of EASTWOOD BIO-MED CDA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.